Cancer is a scary disease, and many people pale upon hearing that they are suffering from this terrible disease. This illness is also one which many researchers, scientists and companies are talking about day in day out, trying to find “true cures”. However, if we look at the economics behind the development and distribution of Cancer drugs, there exists many doubtful areas we want to focus on subsequently and for today, we will just look at what has been happening this past week.
Cancer news – 22 August 2017
- Colorado Rockies Pitcher, Chad Bettis Back On After Cancer Treatment
Cancer is a disease which can be conquered for some people, and from these people we learn courage, grit and resilience. This week, we see Rockies Pitcher, Chad Bettis making first start after being diagnosed with testicular cancer last year and subsequently went through treatment (CSN Philly, 2017). He worked hard to get back into shape and on top of his game to pitch for the Rockies.
- “Promise” In New Cancer Treatments
In a report published by Morningstar, they talked about how the market for new immuno-oncology drugs is growing and being fortified and there are suitable opportunities for both investors (to make money) and patients (to live longer) (Morningstar, 2017). Our stance is that with the rush to get new drugs out in the market, are we prioritizing quantity over quality? We feel that despite being public companies, the major pharmaceutical companies are not sufficiently transparent.
- Hong Kong Opening Its First Cancer Centre
Hong Kong is opening its first Cancer centre in 2025 after receiving a HK$1.24 billion donation from the Hong Kong Jockey Club. The aim of the centre is too explore ways to treat patients in an innovative and incisive manner for the different kinds of Cancer, which claims an average of 14,000 lives annually (SCMP, 2017).
From the news covered today, we see that there is a massive investment of funds into Cancer as a disease. However, perhaps one question to raise would be on the effectiveness of funds used. Who is the supervisor before funds are disbursed? Globally, Cancer affects tens of millions of people and more monitoring is required to move forward with a reliable cure in the future.